Yearly Archives: 2011

On March 3-4, 2011, the Seaver Autism Center co-organized the First International Phelan-McDermid Syndrome Symposium. The Symposium brought researchers, clinicians, and parent advocacy groups together to discuss 22q13 deletion syndrome, Shank3, and the development and implementation of novel therapeutics. Dr. … Continue reading →

A study headed by Jacques Michaud from the University of Montreal identified a de novo splice site mutation in the SHANK3 gene in a boy with mild intellectual disability. This mutation changes the assembly of the protein during its synthesis and … Continue reading →

Dr. Buxbaum and the Seaver Autism Center are proud to join the Singer family, and Team Drive4Rebecca in the New York City Triathlon on August 7, 2011. The Drive4Rebecca is a proud supporter of the groundbreaking research underway at the Seaver … Continue reading →

The  Seaver Autism Center Advances in Autism Conference will be held on Sunday, April 3, 2011. Chaired by Dr. Joseph Buxbaum, Director of the Seaver Autism Center, the conference is designed for healthcare professionals, educators, social workers and family members, … Continue reading →

A new study with a woman with Phelan-McDermid Syndrome (PMS) identifies the smallest published SHANK3 deletion to date. The fact that this small deletion results in the full manifestations of PMS reinforces the finding that disruption of the SHANK3 gene … Continue reading →

Science Magazine featured the new mouse model that has a loss of one copy of the SHANK3 gene. This model was created by Dr. Joseph Buxbaum and studies by him and other investigators at the Seaver Autism Center at the … Continue reading →

In December, Dr. Buxbaum was awarded the prestigious Joel Elkes Research Award from the American College of Neuropsychopharmacology. Every year the College presents this award to a scientist who has made a significant clinical or translational contribution to neuropsychopharmacology.

At the recent World Congress for Psychiatric Genetics conference in Athens, Greece, Dr. Buxbaum had the honor of receiving the Richard Todd Memorial Award for his ground-breaking work. This award is given for “outstanding contribution to the genetics of child … Continue reading →

A team of researchers, led by Joseph Buxbaum, PhD, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai School of Medicine, created and studied a mouse model that has a loss of one copy of the … Continue reading →